問卷

TPIDB > Principal Investigator

Principal Investigator


China Medical University Hospital (在職)

Division of Cardiovascular Diseases

更新時間:2023-09-19

陳建佑Chen, Jan-Yow
  • Co-Principal Investigator
  • Clinical Trial Experience (year) 12 years 9 個月
  • D2740@mail.cmuh.org.tw

篩選

List

3Cases

2017-04-01 - 2018-12-31

Phase III

A PROSPECTIVE, RANDOMIZED, OPEN-LABEL, BLINDED ENDPOINT EVALUATION (PROBE) PARALLEL GROUP STUDY COMPARING EDOXABAN VS. VKA IN SUBJECTS UNDERGOING CATHETER ABLATION OF NON-VALVULAR ATRIAL FIBRILLATION (ELIMINATE-AF)
  • Condition/Disease

    Non-valvular atrial fibrillation (AF)

  • Test Drug

    Edoxaban (DU-176b)

Participate Sites
6Sites

Terminated5Sites

2006-12-18 - 2010-09-07

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
13Sites

Terminated13Sites

2019-08-20 - 2021-08-02

Phase I

A phase I, open label study to evaluate the safety and to explore efficacy of allogeneic umbilical cord mesenchymal stem cells in patients with ST-elevation acute myocardial infarction
  • Condition/Disease

    Acute Myocardial Infarction

  • Test Drug

    UMSC01

Participate Sites
1Sites

Recruiting1Sites

蕭連城
China Medical University Hospital

Division of Cardiovascular Diseases